Last reviewed · How we verify
Drug-Induced Pyridoxine Deficiency — Treatment Landscape & Competitive Intelligence
1 marketed
0 Phase 3
0 Phase 2
Live · 30-min refresh
Marketed treatment landscape
| Drug | Generic | Sponsor | Class | Target | Line of therapy | First approval |
|---|---|---|---|---|---|---|
| Pyridoxine Hydrochloride | PYRIDOXINE | Pfizer | Vitamin C [EPC] | Cystathionine beta-synthase | 1993-01-01 |
Phase 3 pipeline
Phase 2 pipeline
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Sponsor landscape
- Pfizer · 1 drug in Drug-Induced Pyridoxine Deficiency
Subscribe to ongoing alerts
Every new regulatory action, PDUFA date, or trial completion in Drug-Induced Pyridoxine Deficiency:
- Drug-Induced Pyridoxine Deficiency treatment updates — RSS
- Drug-Induced Pyridoxine Deficiency treatment updates — Atom
- Drug-Induced Pyridoxine Deficiency treatment updates — JSON
Cite this brief
Drug Landscape (2026). Drug-Induced Pyridoxine Deficiency — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/drug-induced-pyridoxine-deficiency. Accessed 2026-06-10.
Related
- Drug-Induced Pyridoxine Deficiency full disease profile — treatment pathway, diagnostics, guidelines
- Browse all CI briefs
- Build a custom feed
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing